Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Acta Anatomica Sinica ; (6): 425-430, 2020.
Article Dans Chinois | WPRIM | ID: wpr-1015555

Résumé

Objective To investigate the effect of obesity on the expression of inflammatory factors, and to explore the molecular mechanism of inflammatory factors in the adipose tissue. Methods Twenty Lep

2.
Journal of Experimental Hematology ; (6): 646-651, 2019.
Article Dans Chinois | WPRIM | ID: wpr-771904

Résumé

OBJECTIVE@#To investigate the clinical significance of SCIN gene expression and promoter methylation in patients with chronic myeloid leukemia (CML).@*METHODS@#Real-time quantitative PCR was used to detect the expression level of SCIN in mononucleatr cells of bone marrow samples from 64 CML patients and 37 controls. The methylation levels of SCIN promoter in 65 patients with CML and 29 controls were detected by real-time quantitative methylation-specific PCR and bisulfite sequencing PCR.@*RESULTS@#The expression level of SCIN in CML patients was significantly down-regulated (P<0.05), compared with the control group. The down-regulation rate of SCIN expression in CML patients at chronic phase, accelerated phase and blast crisis was 61%, 67% and 75%, respectively. Spearman correlation analysis showed that the expression level of SCIN negatively correlated with the transcript level of BCR-ABL1 (R=-0.315, P<0.05). However, there was no significant difference in clinical parameters such as sex, age, white blood cell count, hemoglobin level, platelet count, chromosome, CML staging and BCL-ABL1 transcript level between low and high SCIN expression groups of CML patients (P>0.05). No significant difference in methylation of SCIN promoter between CML patients and controls, and no correlation between SCIN expression and promoter methylation were observed (P>0.05).@*CONCLUSION@#The SCIN expression is down-regulated in CML patients, which may relate with the pathogenesis that is, BCR-ABL1 fusion gene induces CML tumorigenesis. The down-regulation of SCIN expression may relate with the progression of CML.


Sujets)
Humains , Crise blastique , Méthylation de l'ADN , Régulation négative , Protéines de fusion bcr-abl , Gelsoline , Génétique , Leucémie myéloïde chronique BCR-ABL positive , Génétique , Régions promotrices (génétique)
SÉLECTION CITATIONS
Détails de la recherche